NCT04695327 2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1 Completed
Clinical Trials
7 trialsNCT00019968 2023-10-31
Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001004 2021-11-04
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00003789 2013-07-16
Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg
National Cancer Institute (NCI)
Phase 3 Completed
NCT00629486 2013-04-18
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT00001296 2008-03-04
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00002262 2005-06-24
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 1 Completed